{"name": "Cannabics  Pharmaceuticals",
 "permalink": "cannabics-pharmaceuticals-2",
 "crunchbase_url": "http://www.crunchbase.com/company/cannabics-pharmaceuticals-2",
 "homepage_url": "http://www.cannabics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "cannabics1",
 "category_code": "biotech",
 "number_of_employees": 6,
 "founded_year": 2011,
 "founded_month": 3,
 "founded_day": 1,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "biotech, cancer, chronic-pain, pharmaceuticals, cannabis-pill, vaporizers, pharma, multiple-sclerosis, alzheimer, medical-cannabis, medical, cannabis, ptds-combat, treatment, malignancies, autoimmune-diseases, brain-disorders, attention, cancer-research",
 "alias_list": null,
 "email_address": "info@cannabics.com",
 "phone_number": "",
 "description": "Cannabis medicines",
 "created_at": "Fri Jan 11 15:33:51 UTC 2013",
 "updated_at": "Tue Mar 05 04:19:43 UTC 2013",
 "overview": "\u003Cp\u003ECannabics Pharmaceuticals researches and develops advanced cannabinoid based medicines. Cannabics was founded in 2011 by a group of entrepreneurs and researchers from the fields of Molecular biology, cancer research and pharmacology.\nWe are setting forth a new approach in the science of personalized anti cancer treatment.\nIn 2012 we established our research division and we are currently running research on integrated cannabinoid compounds.\nCannabics\u0026#8217; aim is to cure patients with diverse malignancies.\nThe company\u2019s research and development laboratories are located in Israel.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       42],
      "assets/images/resized/0022/9806/229806v2-max-150x150.png"],
     [[250,
       70],
      "assets/images/resized/0022/9806/229806v2-max-250x250.png"],
     [[316,
       89],
      "assets/images/resized/0022/9806/229806v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [{"name": "Cannabics SR - A patented sustained release cannabinoid pill.",
    "permalink": "cannabics-sr-a-patented-sustained-release-cannabinoid-pill",
    "image": null},
   {"name": "Cannabics IN - Capsules for dry powder inhalers.",
    "permalink": "cannabics-in-capsules-for-dry-powder-inhalers",
    "image": null},
   {"name": "Cannabics VP \u2013 Condensed pills for use in standard Vaporizers.",
    "permalink": "cannabics-vp-condensed-pills-for-use-in-standard-vaporizers",
    "image": null}],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Research  Laboratories",
    "address1": "",
    "address2": "",
    "zip_code": "38900",
    "city": "Hadera",
    "state_code": null,
    "country_code": "ISR",
    "latitude": 32.442785,
    "longitude": 34.920878},
   {"description": "USA Office",
    "address1": "",
    "address2": "",
    "zip_code": "",
    "city": "Palo Alto",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Cannabics Inc. Filed a new patent to the U.S. Patent Registration USPTO, related to development of cannabis extended release formulation.",
    "stoned_year": 2012,
    "stoned_month": 12,
    "stoned_day": 1,
    "source_url": "http://www.cannabics.com",
    "source_text": null,
    "source_description": "Yaron",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cannabics  Pharmaceuticals",
      "permalink": "cannabics-pharmaceuticals-2"}},
   {"description": "Cannabics Inc. have started research on divers cannabinoid compounds targeted for specific malignancies.",
    "stoned_year": 2013,
    "stoned_month": 1,
    "stoned_day": 4,
    "source_url": "http://www.cannabics.com",
    "source_text": null,
    "source_description": "Yaron",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cannabics  Pharmaceuticals",
      "permalink": "cannabics-pharmaceuticals-2"}},
   {"description": "Cannabics Inc. have launched its new 25mg cannabinoid pill with a 12 hours therapeutic window and a low psychoactive effect.",
    "stoned_year": 2013,
    "stoned_month": 2,
    "stoned_day": 18,
    "source_url": "http://www.cannabics.com",
    "source_text": null,
    "source_description": "Yaron Shalev",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cannabics  Pharmaceuticals",
      "permalink": "cannabics-pharmaceuticals-2"}},
   {"description": "Cannabics Inc. Filed a new patent to the U.S. Patent Registration, related to magnetic and sonic targeting of cannabinoids. ",
    "stoned_year": 2013,
    "stoned_month": 2,
    "stoned_day": 28,
    "source_url": "http://www.cannabics.com",
    "source_text": null,
    "source_description": "Yaron",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cannabics  Pharmaceuticals",
      "permalink": "cannabics-pharmaceuticals-2"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        91],
       "assets/images/resized/0022/9807/229807v2-max-150x150.png"],
      [[250,
        152],
       "assets/images/resized/0022/9807/229807v2-max-250x250.png"],
      [[450,
        274],
       "assets/images/resized/0022/9807/229807v2-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}